Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2025-12-24 @ 5:31 PM
NCT ID:
NCT04194268
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed, inoperable primary or local recurrent pancreatic cancer
* Written informed consent (must be available before enrollment in the trial)
* Karnofsky performance score \> 60 or ECOG-status 0/1 (at least: patient should be able to take care of himself, although daily-life activity or work is not possible)
* Age ≥ 18 years
Exclusion Criteria:
* No clear difference between tumor edge and upper gastrointestinal tract in baseline imaging
* Extensive lymphatic metastases
* Disability of subject to understand character and individual consequences of the clinical trial
* Distant metastases
* Previous radiotherapy of the upper abdomen
* Active medical implants (e.g. pacemaker, defibrillator), contradicting radiotherapy at HIT
* Participation in another clinical study or observation period of competing trials, respectively
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04194268
Study Brief:
Protocol Section:
NCT04194268